Sex differences and racial/ethnic disparities in the presentation and treatment of medullary thyroid cancer

Saiesh Kalva,Sara P Ginzberg,Jesse E Passman,Jacqueline M Soegaard Ballester,Caitlin B Finn,Douglas L Fraker,Rachel R Kelz,Heather Wachtel,Sara P. Ginzberg,Jesse E. Passman,Jacqueline M. Soegaard Ballester,Caitlin B. Finn,Douglas L. Fraker,Rachel R. Kelz
DOI: https://doi.org/10.1016/j.amjsurg.2024.02.009
IF: 3.125
2024-02-01
The American Journal of Surgery
Abstract:BACKGROUND: This study assessed for disparities in the presentation and management of medullary thyroid cancer (MTC).METHODS: Patients with MTC (2010-2020) were identified from the National Cancer Database. Differences in disease presentation and likelihood of guideline-concordant surgical management (total thyroidectomy and resection of ≥1 lymph node) were assessed by sex and race/ethnicity.RESULTS: Of 6154 patients, 68.2% underwent guideline-concordant surgery. Tumors >4 ​cm were more likely in men (vs. women: OR 2.47, p ​< ​0.001) and Hispanic patients (vs. White patients: OR 1.52, p ​= ​0.001). Non-White patients were more likely to have distant metastases (Black: OR 1.63, p ​= ​0.002; Hispanic: OR 1.44, p ​= ​0.038) and experienced longer time to surgery (Black: HR 0.66, p ​< ​0.001; Hispanic: HR 0.71, p ​< ​0.001). Black patients were less likely to undergo guideline-concordant surgery (OR 0.70, p ​= ​0.022).CONCLUSIONS: Male and non-White patients with MTC more frequently present with advanced disease, and Black patients are less likely to undergo guideline-concordant surgery.
surgery
What problem does this paper attempt to address?